Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Treasury Shares (2021 - 2024)

Historic Treasury Shares for Generation Bio (GBIO) over the last 4 years, with Q4 2024 value amounting to $321259.0.

  • Generation Bio's Treasury Shares fell 6851.79% to $321259.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $321259.0, marking a year-over-year decrease of 6851.79%. This contributed to the annual value of $321259.0 for FY2024, which is 6851.79% down from last year.
  • As of Q4 2024, Generation Bio's Treasury Shares stood at $321259.0, which was down 6851.79% from $1.0 million recorded in Q4 2023.
  • Generation Bio's 5-year Treasury Shares high stood at $1.0 million for Q4 2023, and its period low was $13120.0 during Q4 2021.
  • Moreover, its 4-year median value for Treasury Shares was $640390.0 (2022), whereas its average is $578587.8.
  • In the last 5 years, Generation Bio's Treasury Shares soared by 721342.23% in 2022 and then plummeted by 6851.79% in 2024.
  • Over the past 4 years, Generation Bio's Treasury Shares (Quarter) stood at $13120.0 in 2021, then surged by 7213.42% to $959521.0 in 2022, then grew by 6.35% to $1.0 million in 2023, then crashed by 68.52% to $321259.0 in 2024.
  • Its last three reported values are $321259.0 in Q4 2024, $1.0 million for Q4 2023, and $959521.0 during Q4 2022.